HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Elisabeth I Heath Selected Research
Elisabeth I Heath Research Topics
Disease
62
Prostatic Neoplasms (Prostate Cancer)
04/2024 - 09/2005
55
Neoplasms (Cancer)
05/2024 - 04/2007
10
Carcinoma (Carcinomatosis)
01/2022 - 02/2002
7
Carcinogenesis
04/2024 - 08/2006
7
Neoplasm Metastasis (Metastasis)
01/2023 - 10/2016
6
Disease Progression
01/2023 - 01/2013
5
Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 01/2014
5
Adenocarcinoma
01/2022 - 02/2002
5
Fatigue
01/2022 - 10/2019
5
Circulating Neoplastic Cells
01/2022 - 01/2013
4
Pain (Aches)
12/2023 - 12/2010
3
Hypoxia (Hypoxemia)
12/2019 - 03/2008
3
Exanthema (Rash)
10/2019 - 04/2007
3
Barrett Esophagus (Barrett's Esophagus)
01/2009 - 04/2007
3
Esophageal Neoplasms (Esophageal Cancer)
04/2007 - 02/2002
2
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2018
2
Abdominal Pain (Pain, Abdominal)
01/2022 - 10/2019
2
DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes)
01/2022 - 01/2018
2
Neutropenia
10/2019 - 10/2019
2
Diarrhea
10/2019 - 04/2007
2
Hypertension (High Blood Pressure)
03/2016 - 01/2016
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2012 - 04/2007
1
Alopecia (Baldness)
03/2024
1
Body Weight (Weight, Body)
10/2023
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2023
1
Margins of Excision
01/2023
1
Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2022
1
Anemia
01/2022
1
Vomiting
01/2022
Drug/Important Bio-Agent (IBA)
11
Androgens
IBA
01/2023 - 01/2013
10
Biomarkers (Surrogate Marker)
IBA
08/2023 - 10/2009
9
Hormones (Hormone)
IBA
01/2024 - 09/2005
8
Prostate-Specific Antigen (Semenogelase)
IBA
11/2023 - 07/2007
7
enzalutamide
IBA
01/2023 - 10/2018
7
Proteins (Proteins, Gene)
FDA Link
06/2021 - 03/2008
6
Docetaxel (Taxotere)
FDA Link
03/2024 - 02/2002
6
Celecoxib (Celebrex)
FDA Link
10/2009 - 12/2002
5
DNA (Deoxyribonucleic Acid)
IBA
04/2024 - 01/2018
5
Tyrosine Kinase Inhibitors
IBA
01/2023 - 04/2007
5
Platinum
IBA
01/2022 - 04/2007
5
enfortumab vedotin
IBA
01/2022 - 10/2019
4
Immune Checkpoint Inhibitors
IBA
08/2023 - 01/2021
4
Androgen Receptors (Androgen Receptor)
IBA
01/2022 - 01/2012
4
Immunoconjugates (Immunoconjugate)
IBA
01/2021 - 01/2018
3
RNA (Ribonucleic Acid)
IBA
04/2024 - 08/2023
3
taxane
IBA
03/2024 - 10/2019
3
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023 - 06/2021
3
Abiraterone Acetate
IBA
01/2022 - 01/2021
3
Carboplatin (JM8)
FDA Link
Generic
10/2019 - 09/2011
2
Messenger RNA (mRNA)
IBA
05/2024 - 04/2007
2
Everolimus
FDA Link
01/2023 - 08/2019
2
pembrolizumab
IBA
01/2023 - 01/2021
2
cabozantinib
IBA
01/2023 - 01/2019
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
01/2023 - 01/2022
2
Cell-Free Nucleic Acids
IBA
10/2022 - 01/2022
2
Drug Combinations
IBA
01/2022 - 04/2007
2
Histone Deacetylases (Histone Deacetylase)
IBA
01/2022 - 12/2018
2
Histone Deacetylase Inhibitors
IBA
01/2022 - 12/2018
2
Prednisone (Sone)
FDA Link
Generic
12/2021 - 01/2021
2
bicalutamide (Casodex)
FDA Link
Generic
01/2021 - 05/2015
2
Cisplatin (Platino)
FDA Link
Generic
01/2021 - 01/2021
2
B7-H1 Antigen
IBA
10/2019 - 01/2018
2
Anti-Bacterial Agents (Antibiotics)
IBA
12/2018 - 12/2008
2
Ligands
IBA
10/2018 - 11/2012
2
Cytotoxins (Cytolysins)
IBA
01/2018 - 01/2009
2
Gefitinib (Iressa)
FDA Link
11/2016 - 04/2007
2
Growth Factor Receptors
IBA
11/2016 - 08/2006
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016 - 03/2008
2
pazopanib
FDA Link
03/2013 - 08/2012
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2012 - 08/2006
2
Paclitaxel (Taxol)
FDA Link
Generic
12/2011 - 09/2011
2
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
10/2009 - 04/2007
1
Pentoses
IBA
04/2024
1
Phosphates (Orthophosphate)
IBA
04/2024
1
Fatty Acids (Saturated Fatty Acids)
IBA
04/2024
1
antineoplaston A10 (A 10)
IBA
12/2023
1
Conjugated (USP) Estrogens (Premarin)
FDA Link
11/2023
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
10/2023
1
Sodium Fluoride (Ossin)
FDA Link
01/2023
1
olaparib
IBA
01/2023
1
belzutifan
IBA
01/2023
1
Radiopharmaceuticals
IBA
01/2023
1
vistusertib
IBA
01/2022
1
Oxidoreductases (Dehydrogenase)
IBA
01/2022
1
Transferases
IBA
01/2022
1
YM753 compound
IBA
01/2022
1
Estrogen Receptors
IBA
01/2022
1
Ethanol (Ethyl Alcohol)
IBA
01/2022
1
Histones (Histone)
IBA
01/2022
Therapy/Procedure
38
Therapeutics
05/2024 - 03/2008
24
Castration
04/2024 - 01/2013
12
Drug Therapy (Chemotherapy)
12/2023 - 02/2002
6
Radiotherapy
01/2023 - 02/2002
4
Immunotherapy
04/2024 - 08/2006
4
Prostatectomy (Retropubic Prostatectomy)
01/2023 - 10/2009
4
Chemoprevention
04/2016 - 04/2007
3
Precision Medicine
04/2024 - 05/2015
2
Nephrectomy
01/2023 - 08/2019
1
Salvage Therapy
01/2023
1
Intravenous Infusions
01/2022